Apollomics Inc.APLM

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$22.35
Market cap
$65.1M
P/E
—
Revenue (FY)
$0
Net income
-$53.9M
Dividend yield
—
1-year total return
21.2%
Net margin
—
Revenue growth
—
Debt / equity
—

What Apollomics Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year201920202021202220232024
Revenue—$0$0$0$0$0
Net income—-$74.8M-$94.8M-$240.8M-$172.6M-$53.9M
Free cash flow—-$35.8M-$43.4M-$43.2M-$43.2M-$28.8M

More on APLM.

Figures from Apollomics Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.